Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Fanny, Mejías"'
Autor:
Angela Roco, Elena Nieto, Marcelo Suárez, Mario Rojo, Maria Paz Bertoglia, Gabriel Verón, Francisca Tamayo, Annabella Arredondo, Daniela Cruz, Jessica Muñoz, Gabriela Bravo, Patricio Salas, Fanny Mejías, Gerald Godoy, Paulo Véliz, Luis Abel Quiñones
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
BackgroundVitamin K antagonists (VKA) are used as prophylaxis for thromboembolic events in patients with cardiovascular diseases. The most common VKA are warfarin and acenocoumarol. These drugs have a narrow therapeutic margin and high inter-individu
Externí odkaz:
https://doaj.org/article/1cf9186de83e4ef191387e96b937c8fa
Autor:
Mario Rojo MSc, Angela Margarita Roco PhD, Marcelo Suarez MSc, Maria Alejandra Lavanderos PhD, Gabriel Verón MSc, Maria Paz Bertoglia PhD, Annabella Arredondo MD, Elena Nieto MD, Juan Carlos Rubilar MSc, Francisca Tamayo PCh, Daniela Cruz MSc, Jessica Muñoz MSc, Gabriela Bravo MSc, Patricio Salas MD, Fanny Mejías MD, Paulo Véliz MSc, Gerald Godoy MSc, Nelson Miguel Varela PhD, G. Llull MSc, Luis Abel Quiñones PhD
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 26 (2020)
Despite the development of new oral agents over the last decade, vitamin K antagonists (VKAs) remain the most widely used anticoagulants for treating and preventing thromboembolism worldwide. In Chile, the Ministry of Health indicates that acenocouma
Externí odkaz:
https://doaj.org/article/b3dbe867447c497f89dcb22acc4925d3
Autor:
Elena Nieto MD, Marcelo Suarez MSc, Ángela Roco PhD, Juan Carlos Rubilar MSc, Francisca Tamayo PCh, Mario Rojo MSc, Gabriel Verón MSc, Juliana Sepúlveda MD, Fanny Mejías MD, Patricio Salas MD, María Góngora MD, Patricio Andrade MD, Alicia Canales MD, Jorge Carabantes MD, Daniela Cruz MSc, Emma Contreras MSc, Daniela Pavez MSc, Paulina Charo MSc, Gabriela Bravo MSc, Juan Calderón MSc, Carlos Gallardo MD, Patricia Vega MSc, Luis A. Quiñones PhD
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 25 (2019)
Warfarin and acenocoumarol are used in various cardiovascular disorders to improve the prognosis of patients with thromboembolic disease. However, there is a lack of substantial efficacy and safety data on antithrombotic prophylaxis in several countr
Externí odkaz:
https://doaj.org/article/4784ba20189a48229162fc4ca0c1e138
Autor:
Jessica Muñoz, Bryan Leal, Gabriela Bravo, Claudia Patricia López Cabrera, Johana Zambrano, Valeria Moena, Ángela Roco, Suárez M, Víctor Hugo Velásquez Ortiz, Gerald Godoy, Stephanie Bruna, Patricio Salas, Elena Nieto, Fanny Mejías, Luis A. Quiñones, Marcelo Moreno, Marianela Quintana
Publikováno v:
Revista médica de Chile. 147:1273-1282
Background INR is used to monitor the treatment with vitamin K antagonists. A strategy to reduce waiting times for sampling is to measure INR in a capillary sample using a portable point of care (POC) type coagulometer. Aim To evaluate the correlatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::346c8ad2b6db7e005a6913f3f1382e0e
https://doi.org/10.4067/s0034-98872019001001273
https://doi.org/10.4067/s0034-98872019001001273
Autor:
Gerald Godoy, María A Lavanderos, Patricio Salas, Jessica Muñoz, G. Llull, Daniela Cruz, Francisca Tamayo, Gabriela Bravo, Luis A. Quiñones, Fanny Mejías, Nelson Varela, Mario Rojo, Annabella Arredondo, Gabriel Verón, María Paz Bertoglia, Ángela Roco, Juan Carlos Rubilar, Paulo Véliz, Elena Nieto, Suárez M
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 26 (2020)
Clinical and Applied Thrombosis/Hemostasis
Clinical and Applied Thrombosis/Hemostasis
Indexación: Scopus. Despite the development of new oral agents over the last decade, vitamin K antagonists (VKAs) remain the most widely used anticoagulants for treating and preventing thromboembolism worldwide. In Chile, the Ministry of Health indi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::801ea53e5bbd8ad2be4d3acf2f80b738
https://doaj.org/article/b3dbe867447c497f89dcb22acc4925d3
https://doaj.org/article/b3dbe867447c497f89dcb22acc4925d3
Autor:
Ángela, Roco, Elena, Nieto, Marianela, Quintana, Jessica, Muñoz, Víctor, Ortíz, Marcelo, Moreno, Fanny, Mejías, Gerald, Godoy, Johana, Zambrano, Stephanie, Bruna, Gabriela, Bravo, Claudia, Cabrera, Patricio, Salas, Valeria, Moena, Bryan, Leal, Marcelo, Suárez, Luis A, Quiñones
Publikováno v:
Revista medica de Chile. 147(10)
INR is used to monitor the treatment with vitamin K antagonists. A strategy to reduce waiting times for sampling is to measure INR in a capillary sample using a portable point of care (POC) type coagulometer.To evaluate the correlation of CoaguChek P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0cfe6a596384a22ed8acab82319baa33
https://pubmed.ncbi.nlm.nih.gov/32186635
https://pubmed.ncbi.nlm.nih.gov/32186635
Autor:
Patricio Salas, Patricia Vega, Fanny Mejías, Patricio Andrade, Elena Nieto, Ángela Roco, Juan Carlos Rubilar, María Góngora, Carlos Gallardo, Daniela Pavez, Francisca Tamayo, Mario Rojo, Gabriela Bravo, Suárez M, Jorge Carabantes, Luis A. Quiñones, Gabriel Verón, Emma Contreras, Alicia Canales, Daniela Cruz, Juan Calderón, Juliana Sepúlveda, Paulina Charo
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 25 (2019)
Clinical and Applied Thrombosis/Hemostasis
Clinical and Applied Thrombosis/Hemostasis
Warfarin and acenocoumarol are used in various cardiovascular disorders to improve the prognosis of patients with thromboembolic disease. However, there is a lack of substantial efficacy and safety data on antithrombotic prophylaxis in several countr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0222ee58ea8856314d164be75a8b87a
https://doaj.org/article/4784ba20189a48229162fc4ca0c1e138
https://doaj.org/article/4784ba20189a48229162fc4ca0c1e138